These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 18298045

  • 1. Decreased susceptibility to antifungals in respiratory-deficient Kluyveromyces lactis mutants.
    Sarinová M, Straková V, Balková K, Gbelská Y.
    Folia Microbiol (Praha); 2007; 52(5):484-90. PubMed ID: 18298045
    [Abstract] [Full Text] [Related]

  • 2. Impact of mitochondrial function on yeast susceptibility to antifungal compounds.
    Sarinová M, Tichá E, Obernauerová M, Gbelská Y.
    Folia Microbiol (Praha); 2007; 52(3):223-9. PubMed ID: 17702459
    [Abstract] [Full Text] [Related]

  • 3. ERG6 gene deletion modifies Kluyveromyces lactis susceptibility to various growth inhibitors.
    Konecna A, Toth Hervay N, Valachovic M, Gbelska Y.
    Yeast; 2016 Dec; 33(12):621-632. PubMed ID: 27668979
    [Abstract] [Full Text] [Related]

  • 4. Change of cell wall chitin content in amphotericin B resistant Kluyveromyces strains.
    Bahmed K, Bonaly R, Wathier M, Pucci B, Coulon J.
    FEMS Microbiol Lett; 2002 Oct 29; 216(1):99-103. PubMed ID: 12423759
    [Abstract] [Full Text] [Related]

  • 5. [Variation of the sterols from Kluyveromyces lactis and from a resistant mutant by culture in the presence of sublethal doses of amphotericin B].
    Hakkou A, Coulon J, Mpona-Minga M, Bonaly R.
    Can J Microbiol; 1988 Jun 29; 34(6):787-92. PubMed ID: 3264517
    [Abstract] [Full Text] [Related]

  • 6. Amphotericin B resistance and membrane fluidity in Kluyveromyces lactis strains.
    Younsi M, Ramanandraibe E, Bonaly R, Donner M, Coulon J.
    Antimicrob Agents Chemother; 2000 Jul 29; 44(7):1911-6. PubMed ID: 10858353
    [Abstract] [Full Text] [Related]

  • 7. Implication of cell wall constituents in the sensitivity of Kluyveromyces lactis strains to amphotericin B.
    Ramanandraibe E, Younsi M, Coulon J, Loppinet V, Hakkou A, Bonaly R.
    Res Microbiol; 1998 Feb 29; 149(2):109-18. PubMed ID: 9766214
    [Abstract] [Full Text] [Related]

  • 8. A respiratory-deficient mutation associated with high salt sensitivity in Kluyveromyces lactis.
    Goffrini P.
    FEMS Yeast Res; 2007 Mar 29; 7(2):180-7. PubMed ID: 17328740
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
    Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R, Bard M, Rogers PD.
    J Antimicrob Chemother; 2004 Aug 29; 54(2):376-85. PubMed ID: 15201233
    [Abstract] [Full Text] [Related]

  • 13. Extrachromosomal genetics in the yeast Kluyveromyces lactis. Isolation and characterization of antimycin-resistant mutants.
    Brunner A, Mendoza V, Tuena de Cobos A.
    Curr Genet; 1987 Aug 29; 11(6-7):475-82. PubMed ID: 3450410
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of azole resistance in petite mutants of Candida glabrata.
    Brun S, Bergès T, Poupard P, Vauzelle-Moreau C, Renier G, Chabasse D, Bouchara JP.
    Antimicrob Agents Chemother; 2004 May 29; 48(5):1788-96. PubMed ID: 15105136
    [Abstract] [Full Text] [Related]

  • 15. Relation between cell wall chitin content and susceptibility to amphotericin B in Kluyveromyces, Candida and Schizosaccharomyces species.
    Bahmed K, Bonaly R, Coulon J.
    Res Microbiol; 2003 Apr 29; 154(3):215-22. PubMed ID: 12706511
    [Abstract] [Full Text] [Related]

  • 16. Studies on the activity of Kluyveromyces lactis S-adenosylmethionine: delta 24-sterol methyltransferase in presence of polyenic antifungal agents.
    Mukhtar H, Hakkou A, Bonaly R.
    Mycopathologia; 1994 May 29; 126(2):75-83. PubMed ID: 8065434
    [Abstract] [Full Text] [Related]

  • 17. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    Nagayoshi Y, Miyazaki T, Shimamura S, Nakayama H, Minematsu A, Yamauchi S, Takazono T, Nakamura S, Yanagihara K, Kohno S, Mukae H, Izumikawa K.
    PLoS One; 2017 May 29; 12(7):e0180990. PubMed ID: 28700656
    [Abstract] [Full Text] [Related]

  • 18. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
    Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL.
    Antimicrob Agents Chemother; 2012 Aug 29; 56(8):4223-32. PubMed ID: 22615281
    [Abstract] [Full Text] [Related]

  • 19. Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants.
    Sun N, Fonzi W, Chen H, She X, Zhang L, Zhang L, Calderone R.
    Antimicrob Agents Chemother; 2013 Jan 29; 57(1):532-42. PubMed ID: 23147730
    [Abstract] [Full Text] [Related]

  • 20. vga Mutants of Kluyveromyces lactis show cell integrity defects.
    Uccelletti D, Pacelli V, Mancini P, Palleschi C.
    Yeast; 2000 Sep 15; 16(12):1161-71. PubMed ID: 10953087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.